Accès libre

Perfusion magnetic resonance imaging changes in normal appearing brain tissue after radiotherapy in glioblastoma patients may confound longitudinal evaluation of treatment response

Markus Fahlström

Markus Fahlström

Department of Radiology, Surgical Sciences, Uppsala UniversityUppsala, Sweden
Recherchez cet auteur sur
Sciendo|Google Scholar
Fahlström, Markus
, 
Erik Blomquist

Erik Blomquist

Department of Experimental and Clinical Oncology, Immunology, Genetics and Pathology, Uppsala UniversityUppsala, Sweden
Recherchez cet auteur sur
Sciendo|Google Scholar
Blomquist, Erik
, 
Tufve Nyholm

Tufve Nyholm

Department of Radiation Physics and Biomedical Engineering, Radiation Sciences, Umeå UniversityUmeå, Sweden
Recherchez cet auteur sur
Sciendo|Google Scholar
Nyholm, Tufve
 et 
Elna-Marie Larsson

Elna-Marie Larsson

Department of Radiology, Surgical Sciences, Uppsala UniversityUppsala, Sweden
Recherchez cet auteur sur
Sciendo|Google Scholar
Larsson, Elna-Marie
  
06 juin 2018
Perfusion magnetic resonance imaging changes in normal appearing brain tissue after radiotherapy in glioblastoma patients may confound longitudinal evaluation of treatment response's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Catégorie d'article: Research Article
Publié en ligne: 06 juin 2018
Pages: 143 - 151
Reçu: 17 janv. 2018
Accepté: 04 avr. 2018
DOI: https://doi.org/10.2478/raon-2018-0022
Mots clés
© 2018 Markus Fahlström, Erik Blomquist, Tufve Nyholm, Elna-Marie Larsson, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Figure 1

Dose region distribution with corresponding pre-fractionated radiotherapy (pre-FRT) Gd-T1w image. Representative dose region distribution with corresponding pre-FRT GD-T1w image for one patient. Dose distribution was divided into seven binary regions (0–5 Gy, 5–10 Gy, 10–20 Gy, 20–30 Gy, 30–40 Gy, 40–50 Gy and 50–60 Gy). Resection cavity, post-FRT effects and tumour tissue were excluded.
Dose region distribution with corresponding pre-fractionated radiotherapy (pre-FRT) Gd-T1w image. Representative dose region distribution with corresponding pre-FRT GD-T1w image for one patient. Dose distribution was divided into seven binary regions (0–5 Gy, 5–10 Gy, 10–20 Gy, 20–30 Gy, 30–40 Gy, 40–50 Gy and 50–60 Gy). Resection cavity, post-FRT effects and tumour tissue were excluded.

Figure 2

Longitudinal change in global normalised cerebral blood volume (nCBV) and normalised cerebral blood flow (nCBF). Global nCBV and nCBF (mean and 95% CI) graphically displayed for the different examinations in consecutive order. Derived P-values are included, and emphasised in bold and italics if less than 0.05. Corresponding table for regional nCBV and nCBF can be found in S1 and S2 Figures.
Longitudinal change in global normalised cerebral blood volume (nCBV) and normalised cerebral blood flow (nCBF). Global nCBV and nCBF (mean and 95% CI) graphically displayed for the different examinations in consecutive order. Derived P-values are included, and emphasised in bold and italics if less than 0.05. Corresponding table for regional nCBV and nCBF can be found in S1 and S2 Figures.

Figure 3

Dose-dependent relative change and linear regression model for normalised cerebral blood volume (nCBV). Shows regional relative change for nCBV and derived line regression (line and equation). Corresponding figure for normalised cerebral blood flow (nCBF) can be found in S3 Figure.
Dose-dependent relative change and linear regression model for normalised cerebral blood volume (nCBV). Shows regional relative change for nCBV and derived line regression (line and equation). Corresponding figure for normalised cerebral blood flow (nCBF) can be found in S3 Figure.

Mean, standard error of mean (SEM) and change relative pre-fractionated radiotherapy (pre-FRT) for global nCBV and nCBF_ Global normalised cerebral blood volume (nCBV) and normalised cerebral blood flow (nCBF) (mean and SEM), change in percentage relative pre-FRT (mean and SD) and derived P-values from a Wilcoxson matched-pair signed ranks test comparing post-FRT data with pre-FRT data_ Corresponding table for regional nCBV and nCBF can be found in S2 Table

nCBVWMGM $\begin{array}{} \displaystyle \rm nCBV^{GM}_{WM} \end{array}$
Pre-FRT FRTPost-1 FRTPost-2 FRTPost-3
ΔCBV 1.63±0.03 1.53±0.04 1.49±0.05 1.53±0.03
ΔnCBV (%) -6.7±7.7 -4.6±11.7 -6.0±9.3
p-value <0,0001 0,0535 <0,0001
nCBFWMGM $\begin{array}{} \displaystyle \rm nCBF^{GM}_{WM} \end{array}$
Pre-FRT FRTPost-1 FRTPost-2 FRTPost-3
nCBF 1.60±0.03 1.53±0.03 1.37±0.04 1.46±0.03
ΔnCBF (%) -5.1±11.7 -12.5±11.4 -7.5±8.2
p-value 0,0057 <0,0001 <0,0001
nCBVWMWM $\begin{array}{} \displaystyle \rm nCBV^{WM}_{WM} \end{array}$
Pre-FRT FRTPost-1 FRTPost-2 FRTPost-3
nCBV 1.10±0.03 1.06±0.03 1.03±0.03 1.05±0.03
ΔnCBV (%) -4.3±7.6 0.7±11.7 -3.6±11.9
p-value 0,0003 0,3818 0,1197
nCBFWMWM $\begin{array}{} \displaystyle \rm nCBF^{WM}_{WM} \end{array}$
Pre-FRT FRTPost-1 FRTPost-2 FRTPost-3
nCBF 1.09±0.02 1.08±0.03 0.96±0.03 1.05±0.03
ΔnCBF (%) -3.1±7.7 -7.4±10.5 -3.4±10.3
p-value 0,0166 0,0002 0,2267
nCBVGMGM $\begin{array}{} \displaystyle \rm nCBV^{GM}_{GM} \end{array}$
Pre-FRT FRTPost-1 FRTPost-2 FRTPost-3
nCBV 1.00±0.01 0.99±0.01 1.02±0.02 1.0±0.02
ΔnCBV (%) -0.9±4.0 1.7±5.7 -0.4±6.8
p-value 0,1629 0,184 0,6445
nCBFGMGM $\begin{array}{} \displaystyle \rm nCBF^{GM}_{GM} \end{array}$$ $
Pre-FRT FRTPost-1 FRTPost-2 FRTPost-3
nCBF 1.02±0.01 1.01±0.01 1.00±0.01 1.02±0.01
ΔnCBF (%) -0.1±5.1 -2.8±4.7 0.0±4.5
p-value 0,4922 0,0073 0,9252
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Médecine, Médecine clinique, Médecine interne, Hématologie, oncologie, Radiologie
RSS Feed de la revue